ADRIANNA GONZALEZ: Open Payments
NPI 1326509746 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,856 in 128 payments from 20 companies in 2025. Trend: 2023 $1,907 · 2024 $3,187 · 2025 $2,856
Food & beverage: $2,833Education: $23
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $419 |
| ABBVIE INC. | 17 | $413 |
| Galderma Laboratories, L.P. | 16 | $269 |
| Lilly USA, LLC | 9 | $226 |
| PFIZER INC. | 11 | $221 |
| UCB, Inc. | 12 | $213 |
| Incyte Corporation | 9 | $207 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| Janssen Biotech, Inc. | 5 | $122 |
Products named: DUPIXENT, RINVOQ, CIBINQO, Bimzelx, OPZELURA, TALTZ, NEMLUVIO, SKYRIZI.
Industry payments across DC — which companies pay providers there.
